-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 QY76WaGvsTn142+E3rZm1lq3tdQTcBeIYN3ct7V+h5tm0FciELfTyJ4iB/Xn6WLJ
 +W/M8JmXAMzwEhYUSXBTPw==

<SEC-DOCUMENT>0001460300-09-000002.txt : 20090529
<SEC-HEADER>0001460300-09-000002.hdr.sgml : 20090529
<ACCEPTANCE-DATETIME>20090529151341
ACCESSION NUMBER:		0001460300-09-000002
CONFORMED SUBMISSION TYPE:	D/A
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506
FILED AS OF DATE:		20090529
DATE AS OF CHANGE:		20090529
EFFECTIVENESS DATE:		20090529

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cahaba Pharmaceuticals, LLC
		CENTRAL INDEX KEY:			0001460300
		IRS NUMBER:				263991510
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		D/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-129249
		FILM NUMBER:		09861235

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		205-263-2332

	MAIL ADDRESS:	
		STREET 1:		2501 20TH PLACE SOUTH
		STREET 2:		SUITE 275
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			25223-1702
</SEC-HEADER>
<DOCUMENT>
<TYPE>D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0301</schemaVersion>

    <submissionType>D/A</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001460300</cik>
        <entityName>Cahaba Pharmaceuticals, LLC</entityName>
        <issuerAddress>
            <street1>2501 20th Place South</street1>
            <street2>Suite 275</street2>
            <city>Birmingham</city>
            <stateOrCountry>AL</stateOrCountry>
            <zipCode>35223</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>205-263-2332</issuerPhoneNumber>
        <issuerPreviousNameList>
            <value>None</value>
        </issuerPreviousNameList>
        <jurisdictionOfInc>DE</jurisdictionOfInc>
        <entityType>Limited Liability Company</entityType>
        <yearOfInc>
            <withinFiveYears>true</withinFiveYears>
            <value>2008</value>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Madding</firstName>
                <middleName></middleName>
                <lastName>King, III</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>2501 20th Place South</street1>
                <street2>Suite 275</street2>
                <city>Birmingham</city>
                <stateOrCountry>AL</stateOrCountry>
                <zipCode>35223-1702</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
                <relationship>Promoter</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>Manager of Brookline CPMM, LLC, which is Manager of Cahaba Pharmaceuticals, LLC.</relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>J.</firstName>
                <middleName>Rainer</middleName>
                <lastName>Twiford</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>2501 20th Place South</street1>
                <street2>Suite 275</street2>
                <city>Birmingham</city>
                <stateOrCountry>AL</stateOrCountry>
                <zipCode>35223</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
                <relationship>Promoter</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>Manager of Brookline CPMM, LLC, which is Manager of Cahaba Pharmaceuticals, LLC</relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Jimmie</firstName>
                <middleName>Huling</middleName>
                <lastName>Harvey, Jr.</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>2501 20th Place South</street1>
                <street2>Suite 275</street2>
                <city>Birmingham</city>
                <stateOrCountry>AL</stateOrCountry>
                <zipCode>35223-1702</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>James</firstName>
                <middleName>E.</middleName>
                <lastName>Cantrell, Jr.</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>2501 20th Place South</street1>
                <street2>Suite 275</street2>
                <city>Birmingham</city>
                <stateOrCountry>AL</stateOrCountry>
                <zipCode>35223-1702</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Andrew</firstName>
                <middleName>P.</middleName>
                <lastName>Aromando</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>2501 20th Place South</street1>
                <street2>Suite 275</street2>
                <city>Birmingham</city>
                <stateOrCountry>AL</stateOrCountry>
                <zipCode>35223-1702</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Pharmaceuticals</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>No Revenues</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>true</isAmendment>
                <previousAccessionNumber>0001460300-09-000001</previousAccessionNumber>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2009-03-27</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isEquityType>true</isEquityType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
            <clarificationOfResponse></clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>1</minimumInvestmentAccepted>
        <salesCompensationList></salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>2735023</totalOfferingAmount>
            <totalAmountSold>831959</totalAmountSold>
            <totalRemaining>1903064</totalRemaining>
            <clarificationOfResponse></clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>0</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>0</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse></clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>216000</dollarAmount>
                <isEstimate>true</isEstimate>
            </grossProceedsUsed>
            <clarificationOfResponse>$18,000 per month salary to Chief Executive Officer.</clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>Cahaba Pharmaceuticals, LLC</issuerName>
                <signatureName>Matthew A. Aiken</signatureName>
                <nameOfSigner>Matthew A. Aiken</nameOfSigner>
                <signatureTitle>Authorized Company Signatory by Power of Attorney</signatureTitle>
                <signatureDate>2009-05-29</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----